Polyarginine Induces an Antitumor Immune Response through Binding to Toll‐Like Receptor 4
Abstract
A novel function of polyarginine as an activator of the immune system is reported. Single‐molecule fluorescence imaging and single‐molecule force measurements demonstrate that polyarginine binds specifically to the toll‐like receptor 4 (TLR4), inducing receptor dimerization and activation. Moreover, polyarginine induced immune activation inhibits tumor growth. These results suggest the potential use of polyarginine for cancer immunotherapy.Keywords
This publication has 22 references indexed in Scilit:
- Nanoparticle Hydrophobicity Dictates Immune ResponseJournal of the American Chemical Society, 2012
- Subunit counting in membrane-bound proteinsNature Methods, 2007
- Soluble branched (1,4)‐β‐D‐glucans from Acetobacter species enhance antitumor activities against MHC class I‐negative and ‐positive malignant melanoma through augmented NK activity and cytotoxic T‐cell responseInternational Journal of Cancer, 2005
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Simultaneous Blocking of Human Toll-Like Receptors 2 and 4 Suppresses Myeloid Dendritic Cell Activation Induced byMycobacterium bovisBacillus Calmette-Guérin PeptidoglycanInfection and Immunity, 2003
- Topical Imiquimod in the Treatment of Metastatic Melanoma to SkinArchives of Dermatology, 2003
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Polyarginine enters cells more efficiently than other polycationic homopolymersChemical Biology & Drug Design, 2000
- Antitumor Activity of Deoxyribonucleic Acid Fraction From Mycobacterium bovis BCG. I. Isolation, Physicochemical Characterization, and Antitumor Activity2JNCI: Journal of the National Cancer Institute, 1984
- A Phase I–II Trial of Multiple-Dose Polyriboinosinic-Polyribocytidylic Acid in Patients With Leukemia or Solid TumorsJNCI: Journal of the National Cancer Institute, 1976